intravitreal, VEGF Therapy, macula

CLASSIFIEDS

Find the job that’s right for you. PhysiciansJobsPlus allows you to post your resume, receive relevant ophthalmology open position alerts via email and apply for positions online.

Cover Image Not Available

November 2009

Features

Bringing Dry AMD Into Focus
By:  Andrew E. Mathis, PhD, Medical Editor
A recap of dry AMD research and analysis presented at our 2009 annual meeting

Genetic Biomarkers for AMD
By:  Fareed Ali, MD, FRCS(C)

Managing Complications of Radiation Retinopathy
By:  Joanne C. Wen, MD; Tara A. McCannel, MD, PhD

Preclinical and Phase 1 Drugs in Development for Dry AMD: An Overview
By:  Philip J. Rosenfeld, M.D., Ph.D.; John Legarreta, BFA

Vitamins and AMD
By:  Emily Y. Chew, M.D.
What should we know about the current state of nutritional supplementation in AMD?

Questions Remain About ASCs
By:  Andrew E. Mathis, PhD, Medical Editor
What are the barriers that remain to moving more retinal surgeries into ambulatory surgical centers?

ILM Removal as a Prophylaxis of ERM Formation After Vitrectomy
By:  Jerzy Nawrocki, MD. PhD; Janusz Michalewski, MD, PhD; Zofia Michalewska, MD, PhD; Dominik Odrobina, MD, PhD

Perfluoron and Silicone Oil for Complex Retinal Detachments
By:  Steven M. Cohen, MD
A retinal surgeon shares his experience with this new visualization agent

Connecting to a Win-Win?
By:  RenĂ© Luthe, Senior Associate Editor
Image management systems can be particularly helpful to retinal physicians

Estimation on the Incidence and OCT Risk Factors for RPE Tears After Intravitreal Anti-VEGF Injections
By:  Carsten H. Meyer, M.D.; Clement Chan, MD; Christoph Clemens, MD; Frank G. Holz, MD

Complete Spontaneous Resolution of Full-thickness Macular Hole With OCT-documented Restoration of Normal Foveal Contour
By:  Elad Moisseiev, MD; Dafna Goldenberg, MD; Adiel Barak, MD; Anat Loewenstein, MD

Departments

Upfront
By:  Jason S. Slakter, M.D.
From the editor-in-chief

Subspecialty News
By:  Jerry Helzner, Senior Editor
New data from Practices and Trends survey; CMS had planned $7 Avastin reimbursement; Sustained-release Lucentis; and more

Journal Club
Recent notable studies to stimulate discussion

Coding Q&A
By:  Riva Lee Asbell
Medicare rulings on intravitreal injections

Clinical Trial Spotlight
By:  Andrew E. Mathis, PhD, Medical Editor
The One-L LAMA




AWS-#2